616224-62-5 Usage
Uses
Used in Pharmaceutical Synthesis:
2-(Boc)amino-3-chlorobenzoic acid is used as a building block for the synthesis of pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its presence in the molecular structure allows for the creation of a wide range of bioactive compounds with potential medicinal applications.
Used in Organic Synthesis:
In the field of organic synthesis, 2-(Boc)amino-3-chlorobenzoic acid is utilized as a key intermediate for the preparation of complex organic molecules. Its unique structure and functional groups enable the synthesis of various organic compounds with specific properties and applications.
Used in Peptide Chemistry:
2-(Boc)amino-3-chlorobenzoic acid is employed as a coupling reagent in peptide chemistry to facilitate the formation of peptide bonds. The Boc protecting group allows for selective reactions and can be removed under mild acidic conditions, making the compound a valuable tool in the synthesis of peptides and related biomolecules.
Used in Chemical Research:
In the realm of chemical research, 2-(Boc)amino-3-chlorobenzoic acid is used to study the properties and reactivity of various functional groups. Its unique structure provides insights into the behavior of Boc-protected amino acids and their role in chemical reactions and synthesis processes.
Check Digit Verification of cas no
The CAS Registry Mumber 616224-62-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,6,2,2 and 4 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 616224-62:
(8*6)+(7*1)+(6*6)+(5*2)+(4*2)+(3*4)+(2*6)+(1*2)=135
135 % 10 = 5
So 616224-62-5 is a valid CAS Registry Number.
616224-62-5Relevant articles and documents
PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM
-
Page 456, (2008/06/13)
The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides compounds represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C1-C6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.
